Alcoholic and Non-Alcoholic Fatty Liver Disease (eBook)

Drs. Chalasani and Szabo are senior investigators in the field of fatty liver disease and have had extensive federal funding to investigate these areas. They both hold leadership positions and are recognized as experts in the field of fatty liver disease. For example, Dr. Chalasani is the lead author of the multi-society practice guideline on the diagnosis and management of nonalcoholic fatty liver disease& Dr. Szabo is the president-elect of the American Association for the Study of Liver Disease which is the largest liver society in the world. They are also actively practicing clinicians and thus aware of clinically relevant knowledge gaps in the field.

1 Epidemiology and Risk Factors for Alcoholic Liver DiseaseMariana Lazo and Mack C. Mitchell2 Global Epidemiology and Risk Factors for Non-Alcoholic Fatty Liver DiseaseAbhijit Chowdhury and Zobair M. Younossi3 Pathogenesis of Alcoholic Liver DiseaseGavin E. Arteel and David W. Crabb4 Pathogenesis of NAFLD and NASHJacquelyn J. Maher5 Animal Models of Alcoholic Liver DiseaseJun Xu and Hidekazu Tsukamoto6 Animal Models of Nonalcoholic Fatty Liver DiseaseMariana Luisa Verdelho Moutinho Machado and Anna Mae Diehl7 Genetic Basis of Alcoholic and Nonalcoholic Fatty Liver DiseaseSilvia Sookoian and Carlos Jose Pirola8 Clinical Features, Disease Modifiers and Natural History of Alcoholic Liver DiseaseLuis S. Marsano, Vatsalya Vatsalya, Ammar Hassan, and Craig J. McClain9 Nonalcoholic Fatty Liver Disease (NAFLD): Clinical Features, Disease Modifiers, and Natural History Dawn M. Torres and Stephen A. Harrison 10 Diagnostic Approaches and Clinical Endpoints of Treatment in Alcoholic Liver DiseaseJaeyoun Cheong, Eva Stein, and Ramon Bataller11 Diagnostic Considerations and Clinical Endpoints for Nonalcoholic SteatohepatitisArun J. Sanyal12 Pathology of Alcoholic and Non-Alcoholic Fatty Liver DiseasePierre Bedossa and David E. Kleiner13 Hepatic and Extra-Hepatic Malignancies in Alcoholic Liver DiseaseSamir Zakhari, Svetlana Radaeva, Vasilis Vasiliou14 Hepatic and Extra-Hepatic Malignancies in NAFLDFabio Nascimbeni and Vlad Ratziu15 Treatment of Alcoholic Liver Disease Including Emerging Therapies, Novel Targets and Liver TransplantationJan Petrasek and Gyongyi Szabo16 Current and Emerging Therapies for Non-Alcoholic Fatty Liver DiseaseSamer Gawrieh and Naga Chalasani17 Nonalcoholic Fatty Liver Disease in ChildrenHannah I. Awai, Kimberly P. Newton, and Jeffrey B. Schwimmer